Healthy Skepticism Library item: 6687

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Schering-Plough claims patients should not “fear rebound” with Nitro-Dur and Ciba-Geigy claims Transderm-Nitro has “benefits beyond angina prevention”
MaLAM Australian News 1996 Jul-Aug; 4:(7-8):1-2

Abstract:

In an effort to capture larger market shares of antianginal drugs both Schering-Plough and Ciba-Geigy are making claims for their products that are not justified.

Keywords:
*analysis/Australia/developed countries/Nitro-Dur/Transderm-Nitro/Schering-Plough/Ciba-Geigy/MaLAM/Medical Lobby for Appropriate Marketing/quality of information/ comparative advertising/INFLUENCE OF PROMOTION: MARKET SHARE/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES